menu
    • menu

    Company profile for Lyell Immunopharma

    NEW Drugs in Dev: 6
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality. We are focused on advancing the science of t-cell differentiation, functionality, and specificity so that we can develop curative treatments for human disease. We are all about the cells. Our team is comprised of world-class leaders and scientists united by one mission: to develop highly selective, curative cell-based immuno...
    Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality. We are focused on advancing the science of t-cell differentiation, functionality, and specificity so that we can develop curative treatments for human disease. We are all about the cells. Our team is comprised of world-class leaders and scientists united by one mission: to develop highly selective, curative cell-based immunotherapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lyell ImmunopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    SAN FRANCISCO, 400 East Janie Court Suite 301, South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lyell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lyell
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lyell Immunopharma Unveils Q1 2026 Business Highlights
    Lyell Immunopharma Unveils Q1 2026 Business Highlights

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289331/0/en/lyell-immunopharma-reports-business-highlights-and-financial-results-for-the-first-quarter-2026.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Lyell Immunopharma at Needham's 25th Virtual Health Conference
    Lyell Immunopharma at Needham's 25th Virtual Health Conference

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269052/0/en/Lyell-Immunopharma-Announces-Participation-in-25th-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Lyell Immunopharma Reports Q4 2025 and Full-Year Business Update
    Lyell Immunopharma Reports Q4 2025 and Full-Year Business Update

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255090/0/en/Lyell-Immunopharma-Reports-Q4-and-Full-Year-2025-Business-and-Financial-Results.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Lyell Immunopharma Closes $50M Tranche, Names Smital Shah as CFO
    Lyell Immunopharma Closes $50M Tranche, Names Smital Shah as CFO

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251756/0/en/Lyell-Immunopharma-Announces-Closing-of-Additional-50-Million-Tranche-of-Equity-Private-Placement-and-Appointment-of-Smital-Shah-as-Chief-Financial-and-Business-Officer.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Lyell Immunopharma Announces March Investor Participation Conf
    Lyell Immunopharma Announces March Investor Participation Conf

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242588/0/en/Lyell-Immunopharma-Announces-Participation-in-March-Investor-Conferences.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Lyell Immunopharma Ronde-Cel Shows Durable CRs in B-Cell Lymphoma
    Lyell Immunopharma Ronde-Cel Shows Durable CRs in B-Cell Lymphoma

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201148/0/en/Lyell-Immunopharma-Presents-New-Clinical-Data-from-Ongoing-Trial-of-Ronde-Cel-Showing-High-Rates-of-Durable-Complete-Responses-in-Patients-with-Large-B-cell-Lymphoma-at-the-67th-AS.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search